Adherex Eniluracil Phase III To Start Mid ’07; Firm Outlines Fixes For Failed GSK Trials
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Adherex believes it has identified ways to optimize its chemotherapy enhancing agent eniluracil for use in combination with 5-fluorouracil